QuestionSBA
QuestionChoice
Nifedipine, rather than amlodipine, is the first-line calcium channel blocker for Raynaud’s phenomenon.
10035069
c
Prescribe amlodipine
QuestionChoice
This is an inappropriate management strategy as the patient is finding symptoms troublesome, and Raynaud’s is not considered a typical physiological response despite it being fairly common.
10035070
d
Reassure the patient that this is a normal physiological variant
QuestionChoice
This can be trialled if lifestyle factors and keeping warm are ineffective.
10035068
b
Prescribe nifedipine
QuestionChoice
Keeping warm and managing lifestyle factors (e.g. smoking) is the correct first-line management of Raynaud’s phenomenon with no concerning features.
10035067
a
Advise smoking cessation and encourage using gloves to keep warm
QuestionChoice
This may be merited if the patient had joint pain, rashes, positive autoantibodies or raised inflammatory markers on their blood tests. In this case, conservative measures should be trialled before this is considered.
10035071
e
Refer the patient to Rheumatology
QuestionComment
Could this be buerger's syndrome instead of raynauds?
45602
QuestionComment
hit the ward buddy

59068
User
subscriber
Kinase Juice
User
subscriber
Axillary Dermis
Concept
Chapter
2693
6126
Raynaud’s phenomenon
Topic
336
General Practice
19417
Raynaud's phenomenon management includes smoking cessation and keeping extremities warm to alleviate symptoms.
A 27-year-old male smoker has painful pallor of his fingers in the cold, followed by cyanosis then erythema.

He denies joint pain or rashes, or any family history of connective tissue disease.

His recent blood tests including ANA and ESR were all negative.

What is the most appropriate initial management?
a